Annual CFF
$1.11 M
+$1.10 M+13623.46%
December 31, 2023
Summary
- As of February 7, 2025, BJDX annual cash flow from financing activities is $1.11 million, with the most recent change of +$1.10 million (+13623.46%) on December 31, 2023.
- During the last 3 years, BJDX annual CFF has fallen by -$213.50 thousand (-16.11%).
- BJDX annual CFF is now -95.07% below its all-time high of $22.53 million, reached on December 31, 2021.
Performance
BJDX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$371.00 K
-$7.89 M-104.93%
September 30, 2024
Summary
- As of February 7, 2025, BJDX quarterly cash flow from financing activities is -$371.00 thousand, with the most recent change of -$7.89 million (-104.93%) on September 30, 2024.
- Over the past year, BJDX quarterly CFF has dropped by -$367.90 thousand (-11867.74%).
- BJDX quarterly CFF is now -101.93% below its all-time high of $19.26 million, reached on December 31, 2021.
Performance
BJDX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$9.93 M
-$1.55 M-13.48%
September 30, 2024
Summary
- As of February 7, 2025, BJDX TTM cash flow from financing activities is $9.93 million, with the most recent change of -$1.55 million (-13.48%) on September 30, 2024.
- Over the past year, BJDX TTM CFF has increased by +$8.82 million (+793.48%).
- BJDX TTM CFF is now -56.48% below its all-time high of $22.82 million, reached on March 31, 2022.
Performance
BJDX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
BJDX Cash From Financing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +10000.0% | -10000.0% | +793.5% |
3 y3 years | -16.1% | -100.0% | -48.4% |
5 y5 years | -26.5% | -100.0% | -48.4% |
BJDX Cash From Financing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -95.1% | >+9999.0% | -101.9% | at low | -56.5% | >+9999.0% |
5 y | 5-year | -95.1% | >+9999.0% | -101.9% | at low | -56.5% | +3515.1% |
alltime | all time | -95.1% | >+9999.0% | -101.9% | at low | -56.5% | +3515.1% |
Bluejay Diagnostics Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$371.00 K(-104.9%) | $9.93 M(-13.5%) |
Jun 2024 | - | $7.52 M(+170.1%) | $11.48 M(+190.3%) |
Mar 2024 | - | $2.78 M(<-9900.0%) | $3.95 M(+255.8%) |
Dec 2023 | $1.11 M(>+9900.0%) | -$3100.00(-100.3%) | $1.11 M(-1.0%) |
Sep 2023 | - | $1.18 M(<-9900.0%) | $1.12 M(-2202.4%) |
Jun 2023 | - | -$2700.00(-95.4%) | -$53.40 K(+5.3%) |
Mar 2023 | - | -$58.80 K(-825.9%) | -$50.70 K(-725.9%) |
Dec 2022 | $8100.00 | $8100.00(>+9900.0%) | $8100.00(-100.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2022 | - | $0.00(0.0%) | $19.26 M(-5.2%) |
Jun 2022 | - | $0.00(0.0%) | $20.31 M(-11.0%) |
Mar 2022 | - | $0.00(-100.0%) | $22.82 M(+1.3%) |
Dec 2021 | $22.53 M(+1600.0%) | $19.26 M(+1736.1%) | $22.53 M(+589.4%) |
Sep 2021 | - | $1.05 M(-58.2%) | $3.27 M(+47.3%) |
Jun 2021 | - | $2.51 M(-963.0%) | $2.22 M(-863.0%) |
Mar 2021 | - | -$290.80 K | -$290.80 K |
Dec 2020 | $1.33 M(-12.3%) | - | - |
Dec 2019 | $1.51 M | - | - |
FAQ
- What is Bluejay Diagnostics annual cash flow from financing activities?
- What is the all time high annual CFF for Bluejay Diagnostics?
- What is Bluejay Diagnostics annual CFF year-on-year change?
- What is Bluejay Diagnostics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Bluejay Diagnostics?
- What is Bluejay Diagnostics quarterly CFF year-on-year change?
- What is Bluejay Diagnostics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Bluejay Diagnostics?
- What is Bluejay Diagnostics TTM CFF year-on-year change?
What is Bluejay Diagnostics annual cash flow from financing activities?
The current annual CFF of BJDX is $1.11 M
What is the all time high annual CFF for Bluejay Diagnostics?
Bluejay Diagnostics all-time high annual cash flow from financing activities is $22.53 M
What is Bluejay Diagnostics annual CFF year-on-year change?
Over the past year, BJDX annual cash flow from financing activities has changed by +$1.10 M (+13623.46%)
What is Bluejay Diagnostics quarterly cash flow from financing activities?
The current quarterly CFF of BJDX is -$371.00 K
What is the all time high quarterly CFF for Bluejay Diagnostics?
Bluejay Diagnostics all-time high quarterly cash flow from financing activities is $19.26 M
What is Bluejay Diagnostics quarterly CFF year-on-year change?
Over the past year, BJDX quarterly cash flow from financing activities has changed by -$367.90 K (-11867.74%)
What is Bluejay Diagnostics TTM cash flow from financing activities?
The current TTM CFF of BJDX is $9.93 M
What is the all time high TTM CFF for Bluejay Diagnostics?
Bluejay Diagnostics all-time high TTM cash flow from financing activities is $22.82 M
What is Bluejay Diagnostics TTM CFF year-on-year change?
Over the past year, BJDX TTM cash flow from financing activities has changed by +$8.82 M (+793.48%)